We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.